Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-24

FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for sulfamethoxazole and trimethoprim by Prasco Laboratories. This action confirms the approval of the supplement and al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfamethoxazole and Trimethoprim (Sulfamethoxazole and Trimethoprim)

Snippet

SUPPL AP for SULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE AND TRIMETHOPRIM)